FIGURE 2.

Race‐stratified biochemical recurrence‐free^a (A), distant metastasis‐free (B), and overall survival (C) in favorable‐intermediate risk patients. Study outcomes were modeled as time‐to‐event endpoints using race‐stratified Kaplan–Meier estimation curves. Low and favorable‐intermediate risk strata were defined by National Comprehensive Cancer Network criteria. ²¹ AA, African American; CA, Caucasian American; BCR, biochemical recurrence; DM, distant metastasis; OS, overall survival. ^aThe 15‐year estimate cannot be provided among Favorable‐Intermediate due to no BCR events among AA men at this time point